Synthesis and characterization of tris(heteroleptic) diimine complexes of chromium(III)

A preparative procedure of potentially wide applicability is described for the synthesis of previously unreported tris(heteroleptic) [Cr(diimine)₃]³⁺ complexes. The synthetic scheme involves the sequential addition of three different diimine ligands, and employs CrCl₃ · 6H₂O as the initial Cr(III) reagent. The synthesis and characterization of the complexes [Cr(TMP)(phen)(diimine′)]³⁺ are reported (where TMP = 3,4,7,8-tetramethyl-1,10-phenanthroline, phen = 1,10-phenanthroline; and diimine′ is either bpy = 2,2′-bipyridine, Me₂bpy = 4,4′-dimethyl-2,2′-bipyridine, 5-Clphen = 5-chloro-1,10-phenanthroline, or DPPZ = dipyridophenazine). Chiral capillary electrophoresis and electrospray mass spectrometry were essential aids in determining the presence or absence of diimine ligand scrambling. Utilizing emission and electrochemical data obtained on these compounds, the oxidizing power of the lowest lying excited state (²E_g(O_h)) was calculated, and was found to vary in a systematic fashion with diimine ligand type.     

Synthesis, crystal structure, electronic structure, bonding, photoluminescence and spectroscopic property investigations of a mononuclear 1,10-phenanthroline and 5-bromo-salicylate ternary indium(III) complex

The synthesis, X-ray structure, electronic structure, bonding, photoluminescence, spectroscopic property and characterization of an indium(III) complex, [In(Hbsac)₃(phen)] (1) (H₂bsac = 5-bromo-salicylic acid, and phen = 1,10-phenanthroline) are presented. Complex 1 is octacoordinate and carboxylate chelating, being novel and rarely reported for main group complexes. The electronic structure, bonding and the charge transfer properties of light excitation and light emission are discussed in detail using first-principles theory, including partial density of states (PDOSs), crystal orbital overlap population (COOP), the density functional theory (DFT/TDDFT) analysis schemes. The charge transfer is mainly π → π^∗ intraligand charge transfer transition (ILCT) for excitation, and π → π^∗ ligand-to-ligand charge transfer transition (LL′CT) for emission in nature.     

Synthesis, characterization and photophysical properties of mixed ligand tris(polypyridyl)chromium(III) complexes, [Cr(phen)2L]

A series of new heteroleptic, tris(polypyridyl)chromium(III) complexes, [Cr(phen)₂L]³⁺ (L = substituted phenanthrolines or bipyridines), has been prepared and characterized, and their photophyical properties in a number of solvents have been investigated. X-ray crystallography measurements confirmed that the cationic (3+) units contain only one ligand L plus two phenanthroline ligands. Electrochemical and photophysical data showed that both ground state potentials and lifetime decays are sensitive to ligand structure and the nature of the solvent with the exception of compounds containing L = 5-amino-1,10-phenanthroline (aphen) and 2,2′-bipyrimidine (bpm). Addition of electron-donating groups in the ligand structure shifts redox potentials to more negative values than those observed for the parent compound, [Cr(phen)₃]³⁺. Emission decays show a complex dependence with the solvent. The longest lifetime was observed for [Cr(phen)₂(dip)]³⁺ (dip = 4,7-diphenylphenanthroline) in air-free aqueous solutions, τ = 273 μs. Solvent effects are explained in terms of the affinity of hydrophobic complexes for non-polar solvent molecules and the solvent microstructure surrounding chromium units.     

Advances on the interaction of polypyridyl Cr(III) complexes with transporting proteins and its potential relevance in photodynamic therapy

The present study reports a detailed investigation into the interaction of [Cr(phen)₂(dppz)]³⁺ and [Cr(phen)₃]³⁺ with transferrin, the key protein for the transport of Fe³⁺ in blood plasma; its cycle holds promise as an attractive system for strategies of drug targeting to tumor tissues. This can allow us to understand further the role of both complexes as sensitizers in photodynamic therapy (PDT). Chromium(III) complexes, [Cr(phen)₂(dppz)]³⁺ and [Cr(phen)₃]³⁺, (phen = 1,10-phenanthroline and dppz = dipyridophenazine), where dppz is a planar bidentate ligand with an extended π system, have been found to bind strongly with apotransferrin (apoTf) with an intrinsic binding constant, K_b, of (1.8 ± 0.3) × 10⁵ M^− 1 and (1.1 ± 0.1) × 10⁵ M^− 1 at 299 K, for apoTf-[Cr(phen)₂(dppz)]³⁺ and apoTf-[Cr(phen)₃]³⁺, respectively. The interactions of apoTf with the different Cr(III) complexes were assessed employing UV-visible absorption, fluorescence and circular dichroism spectroscopy. The relative fluorescence intensity of the protein decreased when the increasing concentration of Cr(III) complex was added, suggesting that perturbation around the Trp and Tyr residues took place. The analysis of the thermodynamic parameters ΔG, ΔH, ΔS indicated that the presence of the Cr(III) complex stabilizes the protein with a strong entropic contribution. The binding distances and transfer efficiencies for apoTf-[Cr(phen)₂(dppz)]³⁺ and apoTf-[Cr(phen)₃]³⁺ binding reactions were calculated according to Föster theory of non-radiation energy transfer. All these experimental results suggest that [Cr(phen)₂(dppz)]³⁺ and [Cr(phen)₃]³⁺ bind strongly to apoTf indicating that this protein could act as a carrier of these complexes for further applications in PDT.     

Synthesis, characterizations and crystal structures of antimony(III) complexes with nitrogen-containing ligands

Six antimony adducts with N-donor neutral ligands (1,10-phenanthroline, 4,4′-bipyridine) have been obtained following the reaction of antimony halides with phenanthroline and 4,4′-bipyridine. By changing the solvent and stoichiometry, we obtained six different complexes, Sb(phen)Cl₃ (1), Sb(phen)Br₃ (2), Sb₂(phen)₄Br₈ (3) and Sb(bpy)Cl₃ (4), Sb(bpy)₂Cl₃ (5), Sb(bpyH · bpyH₂)Br₆ (6) (where phen = 1,10-phenanthroline, bpy = 4,4′-bipyridine). All the complexes have been characterized via elemental analysis, FT-IR and NMR (¹H, ¹³C) spectroscopy. The crystal structures of complexes 2, 3 and 6 have been determined by X-ray single crystal diffraction.The structural analysis show that the coordination sphere around antimony atom in complex 2 is a distorted square pyramid, coordinated by three bromine atoms and two nitrogen atoms from phen. In complex 3, the central antimony atom is six-coordinated through four bromine atoms and two nitrogen atoms forming a distorted octahedral geometry. Besides that, there are also uncoordinated 1,10-phenanthroline bonded by hydrogen bonds and π-π stacking interactions, which is rarely observed in previous reports. The crystal structure of complex 6 consists of bpyH · bpyH₂ trications and hexabromoantimonate trianions. The antimony atom in the anion has a distorted octahedral environment. Additionally, all complexes present a 3D framework built up by N-H?Br, C-H?Br and C-H?Cl weak hydrogen bonds interactions.     

Vibrational and structural mapping of [Os(bpy)3] and [Os(phen)3]

Structural changes between [Os^IIL₃]²⁺ and [Os^IIIL₃]³⁺ (L: 2,2′-bipyridine; 1,10-phenanthroline) and molecular and electronic structures of the Os^III complexes [Os^III(bpy)₃]³⁺ and [Os^III(phen)₃]³⁺ are discussed in this paper. Mid-infrared spectra in the ν(bpy) and ν(phen) ring stretching region for [Os^II(bpy)₃](PF₆)₂, [Os^III(bpy)₃](PF₆)₃, [Os^II(phen)₃](PF₆)₂, and [Os^III(phen)₃](PF₆)₃ are compared, as are X-ray crystal structures. Absorption spectra in the UV region for [Os^III(bpy)₃](PF₆)₃ and [Os^III(phen)₃](PF₆)₃ are dominated by very intense absorptions (ε = 40 000-50 000 M⁻¹ cm⁻¹) due to bpy and phen intra-ligand π → π^∗ transitions. In the visible region, relatively narrow bands with vibronic progressions of ∼1500 cm⁻¹ appear, and have been assigned to bpy or phen-based, spin-orbit coupling enhanced, ¹π → ³π^∗ electronic transitions. Also present in the visible region are ligand-to-metal charge transfer bands (LMCT) arising from π(bpy) → t_2g(Os^III) or π(phen) → t_2g(Os^III) transitions. In the near infrared, two broad absorption features appear for oxidized forms [Os^III(bpy)₃](PF₆)₃ and [Os^III(phen)₃](PF₆)₃ arising from dπ-dπ interconfigurational bands characteristic of dπ⁵Os^III. They are observed at 4580 and 5090 cm⁻¹ for [Os^III(bpy)₃](PF₆)₃ and at 4400 and 4990 cm⁻¹ for [Os^III(phen)₃](PF₆)₃. The bpy and phen infrared vibrational bands shift to higher energy upon oxidation of Os(II) to Os(III). In the cation structure in [Os^III(bpy)₃](PF₆)₃, the Os^III atom resides at a distorted octahedral site, as judged by ∠N-Os-N, which varies from 78.78(22)° to 96.61(22)°. Os-N bond lengths are also in general longer for [Os^III(bpy)₃](PF₆)₃ compared to [Os^II(bpy)₃](PF₆)₂ (0.010 Å), and for [Os^III(phen)₃](PF₆)₃ compared to [Os^II(phen)₃](PF₆)₂ (0.014 Å). Structural changes in the ligands between oxidation states are discussed as originating from a combination of dπ(Os^II) → π^∗ (bpy or phen) backbonding and charge redistribution on the ligands as calculated by natural population analysis.     

New advances in the study on the interaction of [Cr(phen)2(dppz)]3+ complex with biological models; association to transporting proteins

The present study reports a detailed investigation with the interaction of [Cr(phen)₂(dppz)]³⁺ with serum albumins, the key protein for the transport of drugs in the blood plasma, which allows us to understand further the role of [Cr(phen)₂(dppz)]³⁺ as sensitizer in Photodynamic Therapy (PDT).Chromium(III) complex [Cr(phen)₂(dppz)]³⁺, (dppz = dipyridophenazine and phen = 1,10-phenanthroline), where dppz is a planar bidentate ligand with an extended π system, has been found to bind strongly with bovine and human serum albumins (BSA and HSA) with an intrinsic binding constants, K_b, of (1.7 ± 0.3) × 10⁵ M^− 1 and (2.2 ± 0.3) × 10⁵ M^− 1 at 295 K, respectively. The interactions of serum albumins with [Cr(phen)₂(dppz)]³⁺ were assessed employing fluorescence spectroscopy, circular dichroism and UV-vis absorption spectroscopy. The serum albumins-[Cr(phen)₂(dppz)]³⁺ interactions caused conformational changes with the loss of helical stability of the protein and local perturbation in the domain IIA binding pocket. The relative fluorescence intensity of the albumin (BSA or HSA) bound to the Cr(III) complex decreased, suggesting that perturbation around the Trp 214 residue took place. The analysis of the thermodynamic parameters ΔG, ΔH, ΔS indicated that the hydrophobic interactions played a major role in both BSA-Cr(III) and HSA-Cr(III) association processes. The binding distances and transfer efficiencies for BSA-Cr(III) and HSA-Cr(III) binding reactions were calculated according to the Föster theory of non-radiation energy transfer. All these experimental results suggests that [Cr(phen)₂(dppz)]³⁺ binds to serum albumins, by which these proteins could act as carriers of this complex for further applications in PDT.     

DNA binding and cleavage activity of [Ru(NH3)4(diimine)]Cl2 complexes

The interaction of a series of mixed ligand complexes of the type [Ru(NH₃)₄(diimine)]Cl₂, where diimine=2,2^′-bipyridine (bipy), 1,10-phenanthroline (phen), 5,6-dimethyl-1,10-phenanthroline (5,6-dmp), 4,7-dimethyl-1,10-phenanthroline (4,7-dmp), 2,9-dimethyl-1,10-phenanthroline (2,9-dmp), 3,4,7,8-tetra-methyl-1,10-phenanthroline (Me₄phen), with calf thymus DNA has been studied using absorption, emission and circular dichroic spectral measurements and viscometry and electrochemical techniques. On interaction with DNA the complexes show hypochromism and red-shift in their MLCT band suggesting that the complexes bind to DNA. The magnitude of the binding constant (K_b) obtained from absorption spectral titration varies depending upon the nature of the diimine ligand: Me₄phen > 5,6-dmp > 4,7-dmp > phen suggesting the use of diimine ‘face’ of the octahedral complexes in binding to DNA. The interaction of phen complex possibly involves phen ring partially inserted into the DNA base pairs. In contrast, the methyl-substituted phen complexes would involve hydrophobic interaction of the phen ring in the grooves of DNA, which is supported by hydrogen bonding interactions of the ammonia ligands with the intrastrand nucleobases. Also the shape and size of the phen ligand as modified by the methyl substituents determine the DNA binding site sizes (0.12-0.45 base pairs). The relative emission intensities (I/I₀) of the DNA-bound complexes parallel the variation in K_b values. Almost all the metal complexes exhibit induced CD bands on binding to B DNA, with the 4,7-dmp and Me₄phen complexes inducing certain structural modifications on the biopolymer. DNA melting curves obtained in the presence of metal complexes reveal a monophasic melting of the DNA strands, the Me₄phen complex exhibiting a slightly enhanced tendency to stabilize the double-stranded DNA. There were slight to appreciable changes in the relative viscosities of DNA, which are consistent with enhanced hydrophobic interaction of the methyl-substituted phen rings. Upon interaction with CT DNA, the Me₄phen, 4,7-dmp and 5,6-dmp complexes, in contrast to bipy, phen and 2,9-dmp complexes, show a decrease in anodic peak current in their cyclic voltammograms suggesting that they exhibit enhanced DNA binding. DNA cleavage experiments show that all the complexes induce cleavage of pBR322 plasmid DNA, the Me₄phen and 5,6-dmp complexes being remarkably more efficient than other complexes.     

Synthesis and characterization of one lead(II) photoluminescent coordination polymer with the fumarate ligand

One lead(II) coordination polymer, {[Pb(fum)(phen)]·2H₂O}_n (fum = fumarate, phen = 1,10-phenanthroline), was synthesized through the self-assembly of the lead(II) ion with the mixed fum and phen ligands and characterized by FT-IR spectroscopy, elemental analysis, thermogravimetric analysis, X-ray analysis and solid state photoluminescence spectrum. The compound shows a center-symmetrical dinuclear-based 2D architecture and further assembles into porous 3D supramolecular framework with 1D channel via interlayer π-π stacking interactions. The six-coordinated lead atoms in the complex show hemidirected geometry. The compound exhibits photoluminescence with the maximum emission located in UV region.     

Study on nucleic acid (CT-DNA and yeast tRNA) binding behaviors and cytotoxic properties of a heterodinuclear Ru(II)-Co(III) polypyridyl complex

A heterodinuclear (Ru(II), Co(III)) metal polypyridyl complex [(phen)₂Ru(bpibH₂)Co(phen)₂]⁵⁺ {phen = 1,10-phenanthroline, bpibH₂ = 1,4-bis([1,10]phebanthroline-[5,6-d]imidazol-2-yl)-benzene} has been designed and synthesized. The comparative study on the interactions of the Ru(II)-Co(III) complex with calf thymus DNA (CT-DNA) and yeast tRNA has been investigated by UV-visible spectroscopy, fluorescence spectroscopy, viscosity, as well as equilibrium dialysis and circular dichroism (CD). The antitumor activities of the complex have been evaluated by MTT {3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide} method and Giemsa staining experiment. These results indicate that the structures of nucleic acids have significant effects on the binding behaviors of metal complexes. Furthermore, the complex demonstrates different antitumor activity against selected tumor cell lines in vitro, and can make the cell apoptosis.     

New insights in the DNA-[Cr(phen)2(dppz)] binding and photocleavage properties by the complex with an intercalating ligand

Due to the key role of DNA in cell life and pathological processes, the design of specific chemical nucleases, DNA probes and alkylating agents is an important research area for the development of new therapeutic agents and tools in Biochemistry. Hence, the interaction of small molecules with DNA has attracted in particular a great deal of attention.The aim of this study was to investigate the ability of [Cr(phen)₂(dppz)]³⁺ to associate with DNA and to characterize it as photocleavage reagent for Photodynamic Therapy (PDT).Chromium(III) complex [Cr(phen)₂(dppz)]³⁺, (dppz = dipyridophenazine, phen = 1,10-phenanthroline), where dppz is a planar bidentate ligand with an extended π system, has been found to bind strongly to double strand oligonucleotides (ds-oligo) and plasmid DNA with intrinsic DNA binding constants, K_b, of (3.9 ± 0.3) × 10⁵ M⁻¹ and (1.1 ± 0.1) × 10⁵ M⁻¹, respectively. The binding properties to DNA were investigated by UV-visible (UV-Vis) absorption spectroscopy and electrophoretic studies. UV-Vis absorption data provide clearly that the chromium(III) complex interacts with DNA intercalatively. Competitive binding experiments show that the enhancement in the emission intensity of ethidium bromide (EthBr) in the presence of DNA was quenched by [Cr(phen)₂(dppz)]³⁺, indicating that the Cr(III) complex displaces EthBr from its binding site in plasmid DNA. Moreover, [Cr(phen)₂(dppz)]³⁺, non-covalently bound to DNA, promotes the photocleavage of plasmid DNA under 457 nm irradiation. We also found that the irradiated Cr(III)-plasmid DNA association is able to impair the transforming capacity of bacteria. These results provide evidence confirming the responsible and essential role of the excited state of [Cr(phen)₂(dppz)]³⁺ for damaging the DNA structure. The combination of DNA, [Cr(phen)₂(dppz)]³⁺ and light, is necessary to induce damage. In addition, assays of the photosensitization of transformed bacterial suspensions suggest that Escherichia coli may be photoinactivated by irradiation in the presence of [Cr(phen)₂(dppz)]³⁺. In sum, our results allow us to postulate the [Cr(phen)₂(dppz)]³⁺ complex as a very attractive candidate for DNA photocleavage with potential applications in Photodynamic Therapy (PDT).     

DNA photocleavage activity of cobalt(III) polypyridyl complexes containing dpq ligand

Four cobalt(III) polypyridyl complexes, [Co(phen)_3−n(dpq)_n]³⁺ (phen = 1,10-phenanthroline, dpq = dipyrido[3,2-f:2′,3′-h]-quinoxaline) (n = 0, 1, 2, and 3) were synthesized and the influences of the dpq ligand on the photophysical properties, electrochemical properties, DNA binding affinities, as well as photonuclease activities of the complexes, were examined in detail. The presence of dpq ligand increases the DNA binding affinities of the corresponding complexes remarkably with respect to [Co(phen)₃]³⁺. With the sequential substitution of phen ligand by dpq ligand, the ¹O₂ quantum yields of the corresponding complexes are enhanced greatly. As a result, the photonuclease activities follow the order of [Co(dpq)₃]³⁺ > [Co(phen)(dpq)₂]³⁺ > [Co(phen)₂(dpq)]³⁺ ? [Co(phen)₃]³⁺. It was found all the examined complexes can generate OH upon UV irradiation, and OH is also involved in DNA photocleavage as reactive oxygen species.     

Luminescent ruthenium(II) amidodipyridoquinoxaline biotin complexes that display higher avidin-induced emission enhancement

A series of luminescent ruthenium(II) amidodipyridoquinoxaline biotin (dpq-B) complexes [Ru(N-N)₂(N-N′)](PF₆)₂ (N-N = 2,2′-bipyridine (bpy), 1,10-phenanthroline (phen), 4,7-diphenyl-1,10-phenanthroline (Ph₂-phen); N-N′ = 2-((2-biotinamido)ethyl)amidodipyrido[3,2-f:2′,3′-h]quinoxaline (dpq-C2-B), 2-((6-biotinamido)hexyl)amidodipyrido[3,2-f:2′,3′-h]quinoxaline (dpq-C6-B)) has been designed as new luminescent probes for avidin. The electrochemical and photophysical properties of these complexes have been investigated. Upon irradiation, all the complexes exhibited metal-to-ligand charge-transfer (³MLCT) (dπ(Ru) → π^∗(diimine)) emission in fluid solutions at 298 K and in low-temperature glass. In aqueous buffer, the emission was extremely weak, probably a consequence of hydrogen-bonding interactions between the amide moiety of the dpq-B ligands and the water molecules. The avidin-binding properties of all the complexes have been studied by 4′-hydroxyazobenzene-2-carboxylic acid (HABA) assays, luminescence titrations, kinetics experiments and confocal microscopy using avidin-conjugated microspheres.     

Ruthenium(II) mixed-ligand complexes containing 2-(6-methyl-3-chromonyl)imidazo[4,5-f][1,10]-phenanthroline: Synthesis, DNA-binding and photocleavage studies

Two novel Ru(II) complexes [Ru(bpy)₂(MCMIP)]²⁺ (1) and [Ru(phen)₂(MCMIP)]²⁺ (2) (bpy = 2,2′-bipyridine; phen = 1,10-phenanthroline; MCMIP = 2-(6-methyl-3-chromonyl)imidazo[4,5-f][1,10]-phenanthroline) have been synthesized and characterized by elemental analysis, mass spectra and ¹H NMR. The DNA-binding properties of the complexes were investigated by absorption, emission, melting temperature and viscosity measurements. Experimental results indicate that the two complexes can intercalate into DNA base pairs. Upon irradiation at 365 nm, two Ru(II) complexes were found to promote the cleavage of plasmid pBR 322 DNA from supercoiled form I to nicked form II, and the mechanisms for DNA cleavage by the complexes were also investigated.     

The relationship between the structures of periphery ligands and the DNA binding mode of [Ru(II)(1,10-phenanthroline)(L1L2)dipyrido[3,2-a:2',3'-c]phenazine](n+) (L1=Cl or pyridine and L2=pyridine, n=1,2)

The binding modes of the [Ru(II)(1,10-phenanthroline)(L₁L₂) dipyrido[3,2-a:2′,3′-c]phenazine]²⁺ {[Ru(phen)(py) Cl dppz]⁺ (L₁ = Cl, L₂ = pyridine) and ([Ru(phen)(py)₂dppz]²⁺ (L₁ = L₂ = pyridine)} to native DNA is compared to that of the [Ru(II)(1,10-phenanthroline)₂dipyrido[3,2-a:2′,3′-c]phenazine]²⁺ complex ([Ru(phen)₂dppz]²⁺) by various spectroscopic and hydrodynamic methods including electric absorption, linear dichroism (LD), fluorescence spectroscopy, and viscometric titration. All measured properties, including red-shift and hypochromism in the dppz absorption band, nearly perpendicular molecular plane of the dppz ligand with respect to the local DNA helix axis, prohibition of the ethidium binding, the light switch effect and binding stoichiometry, increase in the viscosity upon binding to DNA, increase in the melting temperature are in agreement with classical intercalation of dppz ligand of the [Ru(phen)₂dppz]²⁺ complex, in which both phenanthroline ligand anchored to the DNA phosphate groups by electrostatic interaction. [Ru(phen)(py)₂ dppz]²⁺ and [Ru(phen)(py) Cl dppz]⁺ complexes had one of the phenanthroline ligand replaced by either two pyridine ligands or one pyridine plus a chlorine ion. They exhibited similar protection from water molecules, interaction with DNA bases, and occupying site that is common with ethidium. The dppz ligand of these two Ru(II) complex were greatly tilted relative to the DNA helix axis, suggesting that the dppz ligand resides inside the DNA and is not perpendicular relative to the DNA helix axis. These observation suggest that anchoring the [Ru(phen)₂dppz]²⁺complex by both phenanthroline is essential for the dppz ligand to be classically intercalated between DNA base-pairs.     

Kinetics of the complexation of nickel(II) with 1,10-phenanthroline and its derivatives in acetonitrile-water mixed solvents

The kinetics of the complexation of Ni(II) with 1,10-phenanthroline(phen), 4,7-dimethyl-1,10-phenanthroline(dmphen), and 5-nitro-1,10-phenanthroline(NO₂phen) in acetonitrile-water mixed solvents of acetonitrile mole fraction x_AN = 0, 0.05, 0.1, 0.2 and 0.3 at 288, 293, 298 and 303 K have been studied by stopped-flow method at ionic strength of 1.0 (NaClO₄) and pH 7.4. The corresponding activation enthalpy, entropy, and free energy were determined from the observed rate constants. The complexation of Ni(II) with the three ligands has comparable observed rate constants; in pure water the observed rate constants are (×10³ dm³ mol⁻¹ s⁻¹) 2.31, 2.57, and 1.38 for phen, dmphen and NO₂phen, respectively. The corresponding activation parameters for the three ligands are, however, considerably different; in pure water the ΔH^‡/ΔS^‡ (kJ mol⁻¹/J K⁻¹ mol⁻¹) are 44.7/−30.2, 19.5/−114.1, and 32.2/−76.9 for phen, dmphen, and NO₂phen, respectively. The effects of solvent composition on the kinetics are also markedly different for the three ligands. The ΔH^‡ and ΔS^‡ showed a minimum at x_AN = 0.1 for phen; for dmphen and NO₂phen, however, maxima at x_AN = 0.2 were observed. Nevertheless, there is an effective enthalpy-entropy compensation for the ΔH^‡/ΔS^‡ of all the three ligands, demonstrating the significant effects of the changes in solvation and solvent structure on the complexation kinetics. As the rate-determining step of Ni(II) complexation is the dissociation of a water molecule from Ni(II), the solvent and ligand dependencies in the Ni(II) complexation kinetics are ascribed to the change in solvation status of the ligands and the altered solvent structures upon changing solvent composition.     

Synthesis, structure, photoluminescence and theoretical studies of an In(III) complex with 2-(2′-hydroxylphenyl)benzoxazole

The synthesis and characterization of [In(pbx)₃] (1) (Hpbx = 2-(2′-hydroxylphenyl)benzoxazole) are presented. The ground and low lying excited electronic states in 1 are studied using density functional theory level (DFT). The optimized geometry is compared to the experimentally observed structure. Time-dependent density functional theory level (TDDFT) is employed to investigate the excited singlet states. The calculated energies of the low lying singlet states in 1 are in considerable agreement with the experimental data. All the low lying transitions are categorized as π → π∗ ligand-to-ligand charge transfer transitions (LLCT) in nature. The emissive state of 1 is assigned as a singlet metal-perturbed π → π∗ ligand-to-ligand charge transfer transition (LLCT).     

Solution studies of lanthanide (III) complexes based on 1,1,1,5,5,5-hexafluoro-2,4-pentanedione and 1,10-phenanthroline Part-I: Synthesis, H NMR, 4f-4f absorption and photoluminescence

Solution studies on the complexes of the type [Ln(hfaa)₃(phen)₂] (Ln = La, Pr and Nd) and [Ln(hfaa)₃phen] (Ln = Nd, Ho, Er and Yb; hfaa stands for the anion of 1,1,1,5,5,5-hexafluoro-2,4-pentanedione and phen stands for 1,10-phenanthroline) are presented. These complexes are synthesized in high yields by an in situ method in which hfaa, ammonium hydroxide, lanthanide chlorides and phen were allowed to react in 3:3:1:1 molar ratio in ethanol. In the case of neodymium both eight- and ten-coordinate complexes are isolated. The paramagnetic shifts of the methine protons of β-diketone have their sign opposed to those of paramagnetic shifts of phen protons and the shifts are dominated by dipolar interactions. The inter- and intramolecular shift ratios have been calculated and discussed. The 4f-4f absorption spectra of the complexes of Pr, Nd, Ho and Er are analyzed. The eight- and ten-coordinate neodymium complexes display distinctively different band shapes of the ⁴G_5/2,²G_7/2 ← ⁴I_9/2 hypersensitive transition. The efficient energy transfer from ligand to Pr(III) is reflected by strong red luminescence of this complex at room temperature.     

Syntheses, structural and spectroscopic investigation (IR, NMR and luminescence) of new terbium and europium acylpyrazolonates

The synthesis and characterization of new lanthanide complexes of formulae [M(Q)₃(H₂O)(EtOH)], NBu₄[M(Q)₄] and [M(Q)₃(L)] (M = Eu or Tb; HQ = 1-phenyl-3-methyl-4-R-pyrazol-5-one: R = cyclopentylcarbonyl, HQ = HQ^CP; R = cyclopentylpropionyl, HQ = HQ^EtCP; L = 1,10-phenanthroline (phen) or 4,7-diphenyl-1,10-phenanthroline (bathophen)) are reported. The crystal structure of the tetrakis (β-diketonate) complex [NBu₄][Eu(Q^ETCP)₄] containing an eight-coordinated Eu atom in a distorted square antiprismatic environment has been determined. Luminescence studies have been performed on selected derivatives: the data suggested a strong influence of the nature of the acyl moiety in Q ligands and of Ph groups in bathophen (with respect to phen) on the luminescence properties.     

Mixed-ligand silver(I) complexes containing bis[2-(diphenylphosphino)phenyl]ether and pyridyl ligands

The reaction of [Ag₂(κ²-P,P′-DPEphos)₂(μ-OTf)₂] (1) (DPEphos = bis(2-(diphenylphosphino)phenyl]ether) with 1,10-phenanthroline (phen) and 4,4′-bipyridine in equimolar ratios afford, respectively, the mononuclear complex [Ag(κ²-P,P′-DPEphos)(phen)][OTf] (2) and the coordination polymer [Ag(κ²-P,P′-DPEphos)(μ-4,4′-bpy)]_n[OTf]_n (3). In complex 3, the silver atoms are bridged by 4,4′-bipyridine units to form a zigzag metallopolymer.